A healthy mouth is home to hundreds of kinds of bacteria, and most do not need to be destroyed.
A new study from Nagoya University in Japan suggests that future gum disease treatment may be able to remove a dangerous bacterium with far greater precision while protecting the rest of this important microbial community.
The research, published in the Journal of Translational Medicine, describes an experimental light-based treatment for periodontitis. Instead of trying to kill bacteria across the mouth, the method is designed to seek out Porphyromonas gingivalis, or P. gingivalis, and destroy it after exposure to near-infrared light.
Periodontitis is an advanced form of gum disease. It develops when long-lasting inflammation affects the gums and the structures that support the teeth, including the jawbone around the tooth roots.
Early gum inflammation may cause redness, swelling or bleeding during brushing. As disease progresses, spaces can form between the gums and teeth, bacteria can spread deeper below the gumline, and the supporting bone can gradually be lost.
- gingivalis has attracted particular attention from researchers because it can upset the normal relationship between oral bacteria and the body’s immune defenses. Scientists sometimes describe it as a key disease-promoting bacterium because its presence can help a harmful bacterial community develop even when the organism itself is not present in very large numbers.
The challenge is that the mouth also needs its normal bacteria. A diverse and balanced microbial community helps occupy the mouth’s surfaces and forms part of the natural environment of the gums, tongue and teeth.
This creates a problem for broad antimicrobial treatments. Antibiotics can be useful in selected cases, but they do not necessarily distinguish between bacteria that contribute to disease and bacteria that are part of a healthy oral community.
Another approach, antimicrobial photodynamic therapy, uses a light-sensitive substance and light to kill microbes. According to the Nagoya University researchers, this treatment can also affect helpful bacteria and healthy cells rather than acting only on the organism causing trouble.
The team wanted something closer to a guided treatment. To create it, they borrowed a concept from a cancer treatment technique in which antibodies are used to carry a light-sensitive chemical directly to selected cells.
Their version uses an antibody called IgY, which can be collected from egg yolks. The researchers immunized hens against P. gingivalis, allowing the birds to produce antibodies that specifically recognize the bacterium.
Those antibodies were joined to a dye that responds to near-infrared light. Once the antibody attaches to P. gingivalis, light activates the dye at the bacterial surface and causes physical damage to the bacterium.
The researchers call the method near-infrared photo-antibacterial targeting therapy, abbreviated NIR-PAT². They compared the technique with more conventional antimicrobial approaches using laboratory experiments and a mouse model of periodontitis.
First, they tested whether the antibody-dye compound could tell P. gingivalis apart from other cells and bacteria. It selectively attached to the target bacterium and did not show the same binding to other tested bacteria or healthy human gum cells.
After near-infrared light was applied, the targeted bacteria were killed. Detailed microscope images showed small holes forming in the outer membrane of P. gingivalis rather than the extensive destruction seen with conventional antimicrobial photodynamic therapy.
This finding could have an important biological advantage. When some bacteria are broken apart, components from their outer membrane, including lipopolysaccharide, can be released and may encourage the immune system to produce more inflammation.
The researchers therefore hope that a more controlled way of killing P. gingivalis could avoid some of the inflammatory effects associated with bacterial destruction. That possibility is promising, but it will require further research to show how important the difference is in actual patients.
Protecting human tissue was another major goal. In the laboratory, the targeted treatment did not significantly damage the human gum cells used in the experiments, while the conventional light-based treatment caused injury and delayed cell recovery.
The scientists then moved to mice with experimentally induced periodontitis. Mice that received NIR-PAT² showed less loss of the bone surrounding the teeth, an important result because bone destruction is one of the most serious consequences of advanced gum disease.
The researchers also studied bacteria in the animals’ saliva. Their treatment reduced P. gingivalis while allowing beneficial Streptococcus populations to remain, suggesting that the therapy could control a dangerous species without unnecessarily clearing away much of the normal bacterial community.
The comparison with antibiotics and standard light therapy was especially notable. Those treatments reduced both harmful and beneficial bacteria, while the new targeted method was much more selective.
This is important because researchers now view the body’s microbial communities as ecosystems rather than simply collections of germs. In an ecosystem, removing everything is not always helpful, because harmless and beneficial organisms can contribute to stability and may make it harder for disease-causing microbes to dominate.
There is also a practical reason the use of IgY could be attractive. Egg-yolk antibodies can be produced in large quantities without relying on the same manufacturing methods used for some other types of antibodies, which could potentially make a future treatment easier and less expensive to produce.
However, periodontitis cannot be reduced to P. gingivalis alone. The disease involves many bacterial species, the body’s inflammatory response, oral hygiene, smoking, diabetes and other factors that can affect a person’s risk and the severity of the condition.
For that reason, the Nagoya University team plans to expand the strategy. The researchers want to use artificial intelligence to analyze existing data on oral microbes, looking for other bacteria that may be useful treatment targets and for patterns showing how different species work together.
In the future, this could allow several harmful organisms to be targeted while leaving the rest of the oral community largely undisturbed. It might also help researchers identify which patients are most likely to benefit from a particular targeted treatment.
The study is particularly interesting because periodontitis has links with health problems elsewhere in the body. People with diabetes, for example, have a complicated two-way relationship with gum disease, while research has also found associations between periodontitis and inflammatory conditions such as rheumatoid arthritis.
The new findings are encouraging, but they remain early-stage evidence. A therapy that works well against one bacterium in laboratory experiments and improves disease in mice may behave differently in people, where dental plaque can be thick and complex and harmful bacteria may be hidden in deep pockets around the teeth.
Human clinical trials will therefore be essential. Researchers will need to determine the best dose, confirm long-term safety, test how effectively near-infrared light reaches bacteria below the gumline, and find out whether the treatment adds meaningful benefits to standard professional cleaning.
The study’s biggest contribution may be the idea behind the treatment rather than an immediate replacement for current dental care. It shows that it may be possible to treat gum disease with much greater precision, attacking specific harmful bacteria instead of treating the entire oral microbiome as an enemy.
If future human studies confirm the results, this approach could help dentists control disease while preserving more of the mouth’s natural bacterial balance. For now, it is a promising experimental strategy that needs careful clinical testing before its real value for patients can be known.
If you care about health, please read studies about turmeric: nature’s golden answer to inflammation, and what to eat to reduce chronic Inflammation.
For more health information, please see recent studies about how a plant-based diet could help ease inflammation ,and Vitamin D deficiency linked to increased inflammation.
Source: Nagoya University.
